share_log

Needham Reiterates Buy on Avidity Biosciences, Maintains $35 Price Target

Needham Reiterates Buy on Avidity Biosciences, Maintains $35 Price Target

Needham重申買入Avidity Biosciences,維持35美元的目標股價
Benzinga ·  03/04 13:10

Needham analyst Joseph Stringer reiterates Avidity Biosciences (NASDAQ:RNA) with a Buy and maintains $35 price target.

Needham分析師約瑟夫·斯金格重申Avidity Biosciences(納斯達克股票代碼:RNA)的買入,並維持35美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論